ID: h-debate-fd4c5d1435ff
Hypothesis

Ceramide-Sphingosine-1-Phosphate Axis Rebalancing via SPHK1 Enhancement

Selective enhancement of sphingosine kinase 1 (SPHK1) activity to shift the ceramide/S1P balance toward the pro-survival S1P pathway.
🧬 SPHK1🎯 Composite 0%💱 $0.51▲1.1%proposed
neurodegeneration
EvidenceModerate (50%)📖 0 cit🗣 1 debates 1 support 0 oppose
✓ All Quality Gates Passed
Mechanistic 0.60 (15%) Evidence 0.55 (15%) Novelty 0.60 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.000 composite

🧪 Overview

Selective enhancement of sphingosine kinase 1 (SPHK1) activity to shift the ceramide/S1P balance toward the pro-survival S1P pathway. This would reduce ceramide-mediated apoptosis and tau hyperphosphorylation while promoting synaptic plasticity through S1P receptor signaling.

Debate provenance: derived from debate `sess_SDA-2026-04-04-frontier-lipidomics-dcdbc360` on question: How do alterations in brain lipid metabolism—including gangliosides, phospholipids, cholesterol transport, and sphingolipids—contribute to amyloidogenesis, tau pathology, and synaptic dysfunction in Alzheimer disease? Examine: (1) APOE-lipid particle composition and functional consequences, (2) gang. Consensus signal: domain_expert, synthesizer, theorist discussed the mechanism terms Ceramide-Sphingosine-1-Phosphate, Enhancement, Rebalancing, S1P, SPHK1, phosphorylation, signaling, synaptic. Novelty signal: synthesizer-consensus.

🧬 Mechanism

🔗 Mechanism from KG for SPHK1

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    SPHK1_deficiency["SPHK1 deficiency"] -->|causes| neurodegeneration["neurodegeneration"]
    SPHK1_deficiency_1["SPHK1_deficiency"] -->|causes| neurodegeneration_2["neurodegeneration"]
    systemic_SPHK1_activation["systemic_SPHK1_activation"] -->|risk factor for| tumor_growth["tumor_growth"]
    style SPHK1_deficiency fill:#4fc3f7,stroke:#333,color:#000
    style neurodegeneration fill:#4fc3f7,stroke:#333,color:#000
    style SPHK1_deficiency_1 fill:#4fc3f7,stroke:#333,color:#000
    style neurodegeneration_2 fill:#4fc3f7,stroke:#333,color:#000
    style systemic_SPHK1_activation fill:#4fc3f7,stroke:#333,color:#000
    style tumor_growth fill:#4fc3f7,stroke:#333,color:#000

⚖️ Evidence

📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — SPHK1

No curated PDB or AlphaFold mapping for SPHK1 yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for SPHK1 →

No DepMap CRISPR Chronos data found for SPHK1.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0002
Events (7d)
1
Price History
▲1.1%

💾 Resource Usage

LLM Tokens
12,502
$0.0750
Total Cost
$0.0750
Metadatasource: v1_phase_c_backfill · origin_type: debate_round_mining
sourcev1_phase_c_backfill
origin_typedebate_round_mining
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.